General Hospital Psychiatry
Volume 31, Issue 6 , Pages 583-585 , November 2009

Melancholic features related to rimonabant

  • Bernardo de Mattos Viana, M.D.

      Affiliations

    • Psychiatry Service, Hospital das Clínicas (HC-UFMG), Federal University of Minas Gerais (UFMG), Belo Horizonte (MG), Brazil
    • Corresponding Author InformationCorresponding author. Serviço de Psiquiatria do Hospital das Clínicas da Universidade Federal de Minas Gerais. Av. Prof. Alfredo Balena 110, Santa Efigênia. Belo Horizonte, MG, Brasil. CEP: 30130-100. Tel.: +55 31 3409 9458; fax: +55 31 3409 9458.
    • ,
  • Hugo Alejandro Cano Prais, M.D., M.Sc.

      Affiliations

    • Departament of Medical Sciences, Federal University of Ouro Preto (UFOP), Ouro Preto (MG), Brazil
    • ,
  • Maurício Viotti Daker, M.D., Ph.D.

      Affiliations

    • Psychiatry Service, Hospital das Clínicas (HC-UFMG), Federal University of Minas Gerais (UFMG), Belo Horizonte (MG), Brazil
    • Department of Mental Health, School of Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte (MG), Brazil

Received 8 October 2008 ,Accepted 30 December 2008.

References 

  1. WHO . Obesity: preventing and managing the global epidemic. WHO Technical Report Series number 894. Geneva: WHO; 2000;
  2. Haslam DW, James WP. Obesity. Lancet. 2005;366:1197–1209
  3. Swinburn B, Egger G. Preventive strategies against weight gain and obesity. Obes Rev. 2002;3:289–301
  4. National Institutes of Health/National Heart, Lung, and Blood Institute Obesity Education Initiative. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Bethesda (MD): US Department of Health and Human Services; 1998;
  5. Halford JC. Pharmacology of appetite suppression: implication for the treatment of obesity. Curr Drug Targets. 2001;2:353–370
  6. Padwal RS, Majumdar SR. Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet. 2007;369:71–77
  7. Di Marzo V, Matias I. Endocannabinoid control of food intake and energy balance. Nat Neurosci. 2005;8:585–589
  8. Curioni C, André C. Rimonabant for overweight or obesity. Cochrane Database Syst Rev. 2006;18:CD006162
  9. Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup A. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet. 2007;370:1706–1713
  10. Mitchell PB, Morris MJ. Depression and anxiety with rimonabant. Lancet. 2007;370:1671–1672
  11. US Food and Drug Administration Advisory Committee . In: Rimonabant Briefing Document: NDA 21-888. Zimulti (rimonabant) Tablets, 20 mg. Rockville (MD): FDA. 2007;http://www.fda.gov/ohrms/dockets/ac/07/briefing/2007-4306b1-fda-backgrounder.pdf(assessed Aug 10, 2008)
  12. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–370
  13. Razavi D, Delvaux N, Farvacques C, Robaye E. Screening for adjustment disorders and major depressive disorders in cancer in-patients. Br J Psychiatry. 1990;156:79–83
  14. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52:69–77
  15. Smolka M, Stieglitz RD. On the validity of the Bech-Rafaelsen Melancholia Scale (BRMS). J Affect Disord. 1999;54:119–128
  16. Bagby RM, Ryder AG, Schuller DR, Marshall MB. The Hamilton Depression Rating Scale: has the gold standard become a lead weight?. Am J Psychiatry. 2004;161:2163–2177
  17. Demyttenaere K, De Fruyt J. Getting what you ask for: on the selectivity of depression rating scales. Psychother Psychosom. 2003;72:61–70
  18. Compton WM, Conway KP, Stinson FS, Grant BF. Changes in the prevalence of major depression and comorbid substance use disorders in the United States between 1991-1992 and 2001-2002. Am J Psychiatry. 2006;163:2141–2147
  19. Nasser M. Culture and eating disorders. In:  Bhugra D,  Bhui K editor. Textbook of Cultural Psychiatry. New York: Cambridge University Press; 2007;p. 292–300

PII: S0163-8343(09)00006-1

doi: 10.1016/j.genhosppsych.2008.12.009

General Hospital Psychiatry
Volume 31, Issue 6 , Pages 583-585 , November 2009

Article Tools